TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Casma Therapeutics Stock

Casma Therapeutics Stock

casmatx.comHealthcare / BioTech & PharmaFounded: 2017

Casma Therapeutics is a biopharma technology company that focuses on removal of damaged cell components to treat and prevent various diseases. Casma Therapeutics aims to reprogram autophagy methods, also known as the removal of infiltrates of cells that can damage and degrade them. The private company has brought together a team of clinical specialists and scientists all with a mission to treat patients where traditional drugs have failed.

Buy or sell Casma Therapeutics stockLearn more about Casma Therapeutics IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Casma Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Casma Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Casma Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Casma Therapeutics investors also invested in these private companies

Euclidean Capital
Amgen Ventures
Mirae Asset Capital
Third Rock Ventures
The Column Group
Schroder Adveq
ONO Venture Investment
Mirae Asset
Eventide
Eisai Co., Ltd.
Astellas Venture Management LLC

Team

Management Team

Daniel Ory
Chief Medical Officer
Frank Gentile
Chief Operating Officer
Keith Dionne
Chief Executive Officer
Leon Murphy
Chief Scientific Officer

Board Members

Bob Tepper
Third Rock Ventures
Cary Pfeffer
Third Rock Ventures
Finny Kuruvilla
Eventide Funds
Gladys Nunez
Amgen
Hiromichi Kimura
Independent Director
Millie Ray
The Column Group
Nagesh Mahanthappa
Scholar Rock, Inc.
Tomotaka Okino
OVI

Frequently Asked Questions About Casma Therapeutics’ Stock

plusminus
Can you buy Casma Therapeutics’ stock?
Casma Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Casma Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Casma Therapeutics’ stock?
Yes, you can sell stock of a private company like Casma Therapeutics. Forge can help you sell your Casma Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Casma Therapeutics’ stock price?
Casma Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Casma Therapeutics’ private market stock price with Forge Data.
plusminus
What is Casma Therapeutics’ stock ticker symbol?
Casma Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Casma Therapeutics in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Precision Neuroscience

Sector
Healthcare / BioTech & Pharma
 
 

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

BioAge

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$439.94MM

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

Life Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$500MM

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

News Highlights

Businesswire 11/21/2022
Casma Therapeutics Raises $46.0 M in Series C Funding
New investors participating in the round include Amgen Ventures, LLC, Astellas Venture Management, Eisai Co., Ltd., Euclidean Capital, Mirae Asset, and Ono Venture Investment.

Trending Companies

Frequently Asked Questions

Updated on: Apr 19, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.